PDB25 COST-EFFECTIVENESS OF INSULIN DEGLUDEC/ASPART VERSUS BIPHASIC INSULIN ASPART IN PATIENTS WITH TYPE 2 DIABETES IN IRAN
Abstract
Authors
P. Saiyarsarai A. Ghazizadeh Khosroshahi J. Khedmati S. Ghaffari F. Soleymani M. Seyyedifar